Latest Breaking News On - Joshuar lamstein - Page 1 : comparemela.com

Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value

18.10.2022 - Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharma’s Pure Play Immuno-Oncology Subsidiary, Duet BioTherapeutics, Independently Valued at $25 Million Scopus Maintains Approximately 90% Ownership Stake in Duet .

Marcin kortylewskiRodd leeds david waldmanScopus biopharmaJoshuar lamsteinAlan horsagerExchange commissionCompany formScopus biopharma inc nasdaqScopus biopharma incCrescendo communicationsDuet being positionedBiopharma incChief executive officerSenior scientific advisor

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors - read this article along with other careers information, tips and advice on BioSpace

United statesIsrael generalCelgene bristol myers squibbRodd leeds david waldmanScopus biopharmaJoshuar lamsteinRaphael rafi hofsteinAlan horsagerZealand pharmaDepartment of neurobiology at harvard medical schoolScopus biopharma incCrescendo communicationsWeizmann institute of scienceExchange commissionCompany formDelaware court

Scopus BioPharma Announces Biotechnology Industry Leader

Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma.

United statesIsrael generalCelgene bristol myers squibbScopus biopharmaJoshuar lamsteinRaphael rafi hofsteinAlan horsagerZealand pharmaDepartment of neurobiology at harvard medical schoolScopus biopharma incWeizmann institute of scienceDelaware courtHebrew university of jerusalemLife sciencesCorporation lawFibrocor therapeutics

Scopus BioPharma Inc (SCPS) Appoints Raphael Hofstein to its Board

Scopus BioPharma Inc (SCPS) Appoints Raphael Hofstein to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesIsrael generalCelgene bristol myers squibbScopus biopharmaJoshuar lamsteinRaphael rafi hofsteinAlan horsagerZealand pharmaDepartment of neurobiology at harvard medical schoolScopus biopharma incWeizmann institute of scienceDelaware courtHebrew university of jerusalemLife sciencesCorporation lawFibrocor therapeutics

Scopus BioPharma Sends Letter Urging Stockholders to Vote

Company’s Director Nominees are Highly Qualified and Experienced with Track Records of Guiding Early-Stage Life Science Companies Executing Strategy to.

United statesRaphael hofsteinJoshuar lamsteinDavids battlemanCommittee contributionScopus biopharma inc nasdaqCommittee of the companyCompany of warrants to purchase six millionStage life science companiesDirector nomineesHighly qualifiedTrack recordsGuiding early stage life scienceIndustry leading portfolioBi functional cancer targetingNon dilutive financing